Anika Therapeutics, Inc.
ANIK
Rank in Stocks
#16762
Anika Therapeutics, Inc. is a company dedicated to joint preservation,... Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and commercialized utilizing their proprietary hyaluronic acid (HA) technology platform. Their comprehensive product lines feature an OA pain management family, which includes established treatments like Monovisc, Orthovisc, Cingal, and Hyvisc, all designed to alleviate discomfort from osteoarthritis. The company's joint preservation and restoration offerings are extensive, comprising approximately 150 bone-sparing joint technology products, alongside solutions for sports medicine soft tissue repair and orthopedic regenerative therapies. Furthermore, Anika leverages its HA expertise in a non-orthopedic product family, developing applications such as adhesion barriers, advanced wound care products, ophthalmic solutions, and ear, nose, and throat treatments. Anika Therapeutics, Inc. was established in 1983 and is based in Bedford, Massachusetts.
Share Price
$14.57
Last synced: 2026-11-09
Market Cap
$194.99M
Change (1 day)
0.14%
Change (1 year)
43.83%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Anika Therapeutics, Inc. (ANIK)
Category
Healthcare
Operating Margin for Anika Therapeutics, Inc. (ANIK)
Operating Margin as of November 2026 TTM: -4.24%
According to Anika Therapeutics, Inc.'s latest financial reports, its current operating margin (TTM) is -4.24%. At the end of 2025 the company had an operating margin of -9.80%.
Operating Margin history for Anika Therapeutics, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -4.24% | -56.73% |
| 2025 | -9.80% | 130.59% |
| 2024 | -4.25% | -707.14% |
| 2023 | 0.70% | -78.26% |
| 2022 | 3.22% | 81.92% |
| 2021 | 1.77% | -108.15% |
| 2020 | -21.71% | -172.66% |
| 2019 | 29.88% | 45.05% |
| 2018 | 20.60% | -48.91% |
| 2017 | 40.32% | -17.63% |
| 2016 | 48.95% | -5.43% |
| 2015 | 51.76% | -11.05% |
| 2014 | 58.19% | 33.99% |
| 2013 | 43.43% | 57.18% |
| 2012 | 27.63% | 28.15% |
| 2011 | 21.56% | 58.88% |
| 2010 | 13.57% | -2.51% |
| 2009 | 13.92% | 17.87% |
| 2008 | 11.81% | -44.74% |
| 2007 | 21.37% | 5.69% |
| 2006 | 20.22% | -29.45% |
| 2005 | 28.66% | 18.72% |
| 2004 | 24.14% | 525.39% |
| 2003 | 3.86% | -115.55% |
| 2002 | -24.83% | -62.10% |
| 2001 | -65.51% | 988.21% |
| 2000 | -6.02% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -103.59% |
US
|
|
| 18.08% | -104.26% |
IE
|
|
| 21.25% | -105.01% |
US
|
|
| 21.05% | -104.96% |
US
|
|
| 28.09% | -106.63% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Anika Therapeutics, Inc.'s operating margin
What is Anika Therapeutics, Inc.'s operating margin?
Anika Therapeutics, Inc.'s operating margin is -4.24%, as of Nov 2026.
What was Anika Therapeutics, Inc.'s operating margin in 2025?
In 2025, Anika Therapeutics, Inc.'s operating margin was -9.80%, compared with -4.25% in 2024.
How has Anika Therapeutics, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Anika Therapeutics, Inc.'s operating margin was highest in 2022 (3.22%) and lowest in 2020 (-21.71%).
How does Anika Therapeutics, Inc.'s operating margin compare with similar companies?
Anika Therapeutics, Inc.'s operating margin (-4.24%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.